β(1)-Blockers Enhance Inotropy of Endogenous Catecholamines in Chronic Heart Failure

Although β(1)-blockers impressively reduce mortality in chronic heart failure (CHF), there are concerns about negative inotropic effects and worsening of hemodynamics in acute decompensated heart failure. May receptor theory dispel these concerns and confirm clinical practice to use β(1)-blockers? I...

Descripción completa

Detalles Bibliográficos
Autores principales: Feuerstein, Thomas J., Schlicker, Eberhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220816/
https://www.ncbi.nlm.nih.gov/pubmed/34179127
http://dx.doi.org/10.3389/fcvm.2021.639562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220816/
https://www.ncbi.nlm.nih.gov/pubmed/34179127
http://dx.doi.org/10.3389/fcvm.2021.639562

Ejemplares similares